TP53 haplotypes and susceptibility to breast cancer.

被引：0
|
作者：
Kristensen, Vessela
Garcia-Closas, Montserrat
Langerod, Anita
Qi, Ying
Yeager, Meredith
Burdett, Laurie
Welch, Robert
Lissowska, Jolanta
Peplonska, Beata
Bardin-Mikolajczak, Alicija
Brinton, Louise
Gerhard, Daniela S.
Perou, Charles
Borresen-Dale, Anne-Lise
Chanock, Stephen
机构：
[1] Univ Oslo, Inst Canc Res, Dept Genet, Oslo, Norway
[2] Norwegian Radium Hosp, Oslo, Norway
[3] NCI, DCEG, Bethesda, MD 20892 USA
[4] NCI, Core Genotyping Facil, ATC, Bethesda, MD 20892 USA
[5] Canc Ctr, Warsaw, Poland
[6] M Sklodowska Curie Inst Oncol, Warsaw, Poland
[7] Nofer Inst Occupat Med, Lodz, Poland
[8] NCI, OCG, Bethesda, MD 20892 USA
[9] UNC, Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA
[10] NCI, POB, CCR, Bethesda, MD 20892 USA
来源：
CANCER RESEARCH | 2006年 / 66卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5388
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Prognostic value of mutant TP53 in basal breast cancer
    Park, J. Y.
    Choi, J. E.
    Lee, J. H.
    Son, G. T.
    Kang, S. H.
    Bae, Y. K.
    Lee, S. J.
    [J]. CANCER RESEARCH, 2013, 73
  • [32] TP53 mutations in familial breast cancer: Functional aspects
    Gasco, M
    Yulug, IG
    Crook, T
    [J]. HUMAN MUTATION, 2003, 21 (03) : 301 - 306
  • [33] Breast Cancer Risk for Women With a TP53 Pathogenic Variant
    Li, Shuai
    Hopper, John L.
    [J]. JCO PRECISION ONCOLOGY, 2024, 8
  • [34] Breast-cancer stromal cells with TP53 mutations
    Campbell, Ian G.
    Qiu, Wen
    Polyak, Kornelia
    Haviv, Izhak
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (15): : 1634 - 1635
  • [35] TP53 mutations as a prognostic factor in women with breast cancer
    Marie Lofthouse
    [J]. Nature Clinical Practice Oncology, 2005, 2 (9): : 428 - 429
  • [36] Clinical implications of germline mutations in breast cancer: TP53
    Katherine Schon
    Marc Tischkowitz
    [J]. Breast Cancer Research and Treatment, 2018, 167 : 417 - 423
  • [37] TP53 Mutations Promote Immunogenic Activity in Breast Cancer
    Liu, Zhixian
    Jiang, Zehang
    Gao, Yingsheng
    Wang, Lirui
    Chen, Cai
    Wang, Xiaosheng
    [J]. JOURNAL OF ONCOLOGY, 2019, 2019
  • [38] Breast cancer risk:tp53 genotyping in a Nigerian population
    Kasvosve, Nancy N.
    Fackenthal, Jim
    Zhang, Jing
    Olopade, Olufunmilayo
    [J]. CANCER RESEARCH, 2010, 70
  • [39] Clinical implications of germline mutations in breast cancer: TP53
    Schon, Katherine
    Tischkowitz, Marc
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2018, 167 (02) : 417 - 423
  • [40] Impact of TP53 mutations in Triple Negative Breast Cancer
    Mitri, Zahi, I
    Abuhadra, Nour
    Goodyear, Shaun M.
    Hobbs, Evthokia A.
    Kaempf, Andy
    Thompson, Alastair M.
    Moulder, Stacy L.
    [J]. NPJ PRECISION ONCOLOGY, 2022, 6 (01)
12345